Fulltext

P-118Tepotinib (MSC2156119J) monotherapy in patients with MET-positive advanced hepatocellular carcinoma with Child-Pugh Class A liver function who have failed sorafenib treatment: phase Ib/II trial

Faivre, S. ; Raymond, E. ; Stammberger, U. ; Sarholz, B. ; Bladt, F.

In: Annals of Oncology, 2015, vol. 26, p. iv34-iv34

Add to personal list
    Title
    • P-118Tepotinib (MSC2156119J) monotherapy in patients with MET-positive advanced hepatocellular carcinoma with Child-Pugh Class A liver function who have failed sorafenib treatment: phase Ib/II trial
    Author
    • Faivre, S.. Oncology Unit, Centre Hospitalo-Universitaire Vaudois (CHUV), Lausanne, Switzerland
    • Raymond, E.. Oncology Unit, Centre Hospitalo-Universitaire Vaudois (CHUV), Lausanne, Switzerland
    • Stammberger, U.. Merck KGaA, Darmstadt, Germany
    • Sarholz, B.. Merck KGaA, Darmstadt, Germany
    • Bladt, F.. Merck KGaA, Darmstadt, Germany
    Document Type
    • Postprint
    Classification
    • Health
    OAI-PMH Identifier
    • oai:doc.rero.ch:300446